Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Combined endoscopic endonasal and bilateral subfrontal approach for a non-functioning pituitary adenoma associated with an internal carotid artery - superior hypophyseal artery aneurysm.

Kino H, Ito Y, Akutsu H, Tanaka S, Hara T, Ishikawa E, Miyamoto H, Matsumaru Y, Matsumura A.

World Neurosurg. 2019 Nov 4. pii: S1878-8750(19)32797-4. doi: 10.1016/j.wneu.2019.10.159. [Epub ahead of print]

PMID:
31698130
2.

Endoscopic endonasal cyst fenestration into the sphenoid sinus using the mucosa coupling method for symptomatic Rathke's cleft cyst: a novel method for maintaining cyst drainage to prevent recurrence.

Kino H, Akutsu H, Tanaka S, Hara T, Miyamoto H, Sakamoto N, Takano S, Masumoto T, Shiigai M, Ishikawa E, Matsumura A.

J Neurosurg. 2019 Nov 1:1-11. doi: 10.3171/2019.8.JNS191103. [Epub ahead of print]

PMID:
31675725
3.

Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.

Hara T, Akutsu H, Takano S, Kino H, Ishikawa E, Tanaka S, Miyamoto H, Sakamoto N, Hattori K, Sakata-Yanagimoto M, Chiba S, Hiyama T, Masumoto T, Matsumura A.

J Neurosurg. 2018 Jul 1:1-10. doi: 10.3171/2018.3.JNS172528. [Epub ahead of print]

PMID:
30074466
4.

Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody.

Miyamae T, Hara T, Hanaya A, Tani Y, Kishi T, Yamanaka H.

Case Rep Rheumatol. 2018 Feb 6;2018:2164312. doi: 10.1155/2018/2164312. eCollection 2018.

5.

Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.

Mori M, Hara T, Kikuchi M, Shimizu H, Miyamoto T, Iwashima S, Oonishi T, Hashimoto K, Kobayashi N, Waki K, Suzuki Y, Otsubo Y, Yamada H, Ishikawa C, Kato T, Fuse S.

Sci Rep. 2018 Jan 31;8(1):1994. doi: 10.1038/s41598-017-18387-7.

6.

Infliximab for the Treatment of Refractory Kawasaki Disease: A Nationwide Survey in Japan.

Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T; Committee of Survey on Infliximab use for Kawasaki disease.

J Pediatr. 2018 Apr;195:115-120.e3. doi: 10.1016/j.jpeds.2017.10.013. Epub 2017 Dec 7.

PMID:
29224935
7.

Combined Endoscopic Endonasal and Transoral Surgery for a Chordoma in the Whole Clivus With Marked Caudal Extension.

Hara T, Akutsu H, Yamamoto T, Tanaka S, Yasuda M, Takano S, Kino H, Miyamoto H, Matsumura A.

Oper Neurosurg (Hagerstown). 2018 Apr 1;14(4):463-464. doi: 10.1093/ons/opx168. No abstract available.

PMID:
28961728
8.

Intradiploic Arachnoid Cyst with Meningothelial Hyperplasia: A Case Report.

Saida H, Ishikawa E, Sakamoto N, Hara T, Terakado T, Masumoto T, Akutsu H, Shibuya M, Yamamoto T, Takano S, Matsumura A.

NMC Case Rep J. 2016 Dec 5;4(1):19-22. doi: 10.2176/nmccrj.cr.2016-0147. eCollection 2017 Jan.

9.

Cranial Base Repair Using Suturing Technique Combined with a Mucosal Flap for Cerebrospinal Fluid Leakage During Endoscopic Endonasal Surgery.

Hara T, Akutsu H, Yamamoto T, Tanaka S, Takano S, Ishikawa E, Matsuda M, Matsumura A.

World Neurosurg. 2015 Dec;84(6):1887-93. doi: 10.1016/j.wneu.2015.08.025. Epub 2015 Sep 1.

PMID:
26341445
10.

Correlations of vascular architecture and angiogenesis with pituitary adenoma histotype.

Takano S, Akutsu H, Hara T, Yamamoto T, Matsumura A.

Int J Endocrinol. 2014;2014:989574. doi: 10.1155/2014/989574. Epub 2014 Nov 9.

11.

Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.

Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.

Ther Apher Dial. 2015 Apr;19(2):171-7. doi: 10.1111/1744-9987.12235. Epub 2014 Sep 26.

PMID:
25257673
12.

Analysis of gender differences in genetic risk: association of TNFAIP3 polymorphism with male childhood-onset systemic lupus erythematosus in the Japanese population.

Kadota K, Mori M, Yanagimachi M, Miyamae T, Hara T, Kanetaka T, Nozawa T, Kikuchi M, Hara R, Imagawa T, Kaneko T, Yokota S.

PLoS One. 2013 Aug 30;8(8):e72551. doi: 10.1371/journal.pone.0072551. eCollection 2013.

13.

Remote Cerebellar Hemorrhage after Removal of a Supratentorial Glioma without Perioperative CSF Loss: A Case Report.

Hara T, Matsuda M, Watanabe S, Nakai K, Yamamoto T, Matsumura A.

Case Rep Surg. 2013;2013:305039. doi: 10.1155/2013/305039. Epub 2013 Feb 21.

14.

Cushing's disease presenting with gastrointestinal perforation: a case report.

Hara T, Akutsu H, Yamamoto T, Ishikawa E, Matsuda M, Matsumura A.

Endocrinol Diabetes Metab Case Rep. 2013;2013:130064. doi: 10.1530/EDM-13-0064. Epub 2013 Nov 18.

15.

Human parechovirus-3 infection in nine neonates and infants presenting symptoms of hemophagocytic lymphohistiocytosis.

Yuzurihara SS, Ao K, Hara T, Tanaka F, Mori M, Kikuchi N, Kai S, Yokota S.

J Infect Chemother. 2013 Feb;19(1):144-8. doi: 10.1007/s10156-012-0420-9. Epub 2012 May 10.

PMID:
22569793
16.

HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period.

Kobayashi-Ishihara M, Yamagishi M, Hara T, Matsuda Y, Takahashi R, Miyake A, Nakano K, Yamochi T, Ishida T, Watanabe T.

Retrovirology. 2012 May 8;9:38. doi: 10.1186/1742-4690-9-38.

17.

[Neonatal herpes simplex type II virus infection complicated with meningitis and virus-associated hemophagocytic syndrome].

Arai C, Nozawa T, Hara T, Kikuchi M, Momomura M, Kizawa T, Tanoshima R, Kita M, Yokosuka T, Miyamae T, Iwasaki S, Imagawa T, Yokota S.

Nihon Rinsho Meneki Gakkai Kaishi. 2012;35(1):87-91. Japanese.

18.

Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.

Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.

J Rheumatol. 2012 Apr;39(4):864-7. doi: 10.3899/jrheum.110877. Epub 2012 Feb 15.

PMID:
22337241
19.

Useful method for evaluation of local irritation using auricular subcutis of rabbits.

Hara K, Matsuoka T, Hara T, Wakabayashi K, Kanda M, Ando R, Yamashita T.

J Toxicol Sci. 2012 Feb;37(1):197-205.

20.

Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.

Yanagimachi M, Naruto T, Miyamae T, Hara T, Kikuchi M, Hara R, Imagawa T, Mori M, Sato H, Goto H, Yokota S.

J Rheumatol. 2011 Apr;38(4):769-74. doi: 10.3899/jrheum.100655. Epub 2011 Jan 15.

PMID:
21239750
21.

Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.

Yanagimachi M, Naruto T, Hara T, Kikuchi M, Hara R, Miyamae T, Imagawa T, Mori M, Kaneko T, Morita S, Goto H, Yokota S.

Br J Clin Pharmacol. 2011 Feb;71(2):237-43. doi: 10.1111/j.1365-2125.2010.03814.x.

22.

Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis.

Yanagimachi M, Miyamae T, Naruto T, Hara T, Kikuchi M, Hara R, Imagawa T, Mori M, Kaneko T, Goto H, Morita S, Mizuki N, Kimura A, Yokota S.

J Hum Genet. 2011 Mar;56(3):196-9. doi: 10.1038/jhg.2010.159. Epub 2010 Dec 23.

PMID:
21179106
23.

Inhibition of active HIV-1 replication by NF-kappaB inhibitor DHMEQ.

Miyake A, Ishida T, Yamagishi M, Hara T, Umezawa K, Watanabe T, Horie R.

Microbes Infect. 2010 May;12(5):400-8. doi: 10.1016/j.micinf.2010.02.004. Epub 2010 Feb 19.

PMID:
20172044

Supplemental Content

Loading ...
Support Center